Main Industry
Biotechnology
Main Product/Service
ExoOne Bio. Co., Ltd. is dedicated to the research and development of novel drugs for degenerative diseases, aiming to enhance human health and usher in a new era of therapeutic efficacy. The indications for these new drugs include optic nerve degeneration, osteoarthritis, and chronic kidney disease, among others.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83414673
Status
Active
Number of Employees
0
Total Paid-in
Capital
284,937,820 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ExoOne Bio. Co., Ltd. is Taiwan's first exosome new drug development company, founded at the end of 2020 by Dr. Tzou-Yien Lin, the former Minister of the Ministry of Health and Welfare. Leveraging its outstanding medical background and rich experience across industry, government, and academia, ExoOne Bio. Co., Ltd. has laid a solid foundation for its development, gradually establishing a unique core technology for exosome purification, identification, and isolation. Its achievements surpass international standards and have been recognized with multiple patents.
In the future, ExoOne Bio. Co., Ltd. will take it as its mission to utilize high-quality exosome biotechnology products to treat degenerative diseases and maintain healthy aging, aspiring to become a global leader in anti-aging and rejuvenation.
(The content above was translated by AI.)
In the future, ExoOne Bio. Co., Ltd. will take it as its mission to utilize high-quality exosome biotechnology products to treat degenerative diseases and maintain healthy aging, aspiring to become a global leader in anti-aging and rejuvenation.
(The content above was translated by AI.)
